SESSION TITLE: Evaluation and Treatment of ILD
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM
PURPOSE: Patients with idiopathic pulmonary fibrosis (IPF) often have a number of cardiovascular risk factors and comorbidities and take a variety of related concomitant medications. The objective of this analysis was to describe the type and prevalence of specific cardiovascular risk factors/comorbidities and related medication use in patients with IPF.